More isn't always better: Expanding and refining prognostic methylation signatures for pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Sherpally, Deepak
Jeepalyam, Sravan
Puram, Harshitha
Manne, Ashish
机构：
[1] Metropolitan Hosp Ctr, New York, NY USA
[2] Stormont Vail Hlth, Topeka, KS USA
[3] Univ Cincinnati, Cincinnati, OH USA
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.769
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：769 / 769
页数：1
相关论文
共 50 条
  • [21] Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
    Tang, Rong
    Liu, Xiaomeng
    Liang, Chen
    Hua, Jie
    Xu, Jin
    Wang, Wei
    Meng, Qingcai
    Liu, Jiang
    Zhang, Bo
    Yu, Xianjun
    Shi, Si
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [22] Early detection of pancreatic ductal adenocarcinoma using methylation signatures in circulating tumour DNA
    Liu, X-D.
    Wu, H.
    Li, Y.
    Liu, X.
    Zhang, Z.
    Yu, L.
    Qin, Z.
    Su, Z.
    Liu, R.
    He, Q.
    Dai, M.
    Liang, Z.
    ANNALS OF ONCOLOGY, 2019, 30 : 261 - +
  • [23] Gasdermin C as a potential prognostic biomarker and its correlation with immune infiltration in pancreatic ductal adenocarcinoma.
    Xia, Xianghou
    Yu, Yang
    Yang, Hongjian
    Zou, Dehong
    Wang, Canming
    Hu, Jiejie
    Mao, Jiefei
    Cai, Xixi
    Yin, Wenjuan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Early detection of pancreatic ductal adenocarcinoma (PDAC) using methylation signatures in circulating tumour DNA
    Liu, X.
    He, Q.
    Su, Z.
    Guo, S.
    Liang, Z.
    Jin, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S792 - S792
  • [25] More isn't always better: antibiotic duration after surgical decortication in pleural empyema
    Freudenberger, Devon C.
    Scheese, Daniel
    Wolfe, Luke G.
    Ramamoorthy, Bhavishya U.
    Burrell, Leslie M.
    Puig, Carlos A.
    Shah, Rachit D.
    Julliard, Walker A.
    JOURNAL OF THORACIC DISEASE, 2024, 16 (06) : 3873 - 3881
  • [26] Protein-informed gene methylation signatures to predict treatment response and outcomes in pancreatic ductal adenocarcinoma
    Manne, Ashish
    Puram, Harshitha
    Sherpally, Deepak
    Jeepalyam, Sravan
    Manne, Upender
    CANCER RESEARCH, 2024, 84 (17)
  • [27] More Isn't Always Better: Time to Derive a Different Strategy for Renal Cell Carcinoma Surveillance
    Merrill, Suzanne B.
    EUROPEAN UROLOGY, 2019, 75 (02) : 265 - 267
  • [28] Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
    Yang, Chengkun
    Wu, Qiongyuan
    Huang, Ketuan
    Wang, Xiangkun
    Yu, Tingdong
    Liao, Xiwen
    Huang, Jianlu
    Zhu, Guangzhi
    Gong, Yizhen
    Han, Chuangye
    Su, Hao
    Qin, Wei
    Peng, Tao
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [29] Non-invasive early detection of pancreatic ductal adenocarcinoma using methylation signatures in circulating tumor DNA
    Gore, Athurva J.
    Dang, Justin
    Fung, Alan
    Xie, Bin
    Liu, Rui
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Tumor budding is a prognostic factor linked to epithelial mesenchymal transition in pancreatic ductal adenocarcinoma. Study report and literature review
    Chouat, Ezzeddine
    Zehani, Alia
    Chelly, Ines
    Njima, Manel
    Maghrebi, Houcine
    Bani, Mohammed Amine
    Njim, Leila
    Zakhama, Abdelfatteh
    Haouet, Slim
    Kchir, Nidhameddine
    PANCREATOLOGY, 2018, 18 (01) : 79 - 84
12345